BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37762115)

  • 1. The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria.
    Tang M; Zhao D; Liu S; Zhang X; Yao Z; Chen H; Zhou C; Zhou T; Xu C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When Combined with Pentamidine, Originally Ineffective Linezolid Becomes Active in Carbapenem-Resistant Enterobacteriaceae.
    Tang M; Qian C; Zhang X; Liu Y; Pan W; Yao Z; Zeng W; Xu C; Zhou T
    Microbiol Spectr; 2023 Jun; 11(3):e0313822. PubMed ID: 37125928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.
    Klobucar K; Jardine E; Farha MA; MacKinnon MR; Fragis M; Nkonge B; Bhando T; Borrillo L; Tsai CN; Johnson JW; Coombes BK; Magolan J; Brown ED
    ACS Infect Dis; 2022 Oct; 8(10):2187-2197. PubMed ID: 36098580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative Membrane Damage as a Mechanism for Pentamidine-Antibiotic Mutual Sensitization.
    Zhou Y; Huang W; Lei E; Yang A; Li Y; Wen K; Wang M; Li L; Chen Z; Zhou C; Bai S; Han J; Song W; Ren X; Zeng X; Pu H; Wan M; Feng X
    ACS Chem Biol; 2022 Nov; 17(11):3178-3190. PubMed ID: 36269311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
    Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
    Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens.
    Wesseling CMJ; Slingerland CJ; Veraar S; Lok S; Martin NI
    ACS Infect Dis; 2021 Dec; 7(12):3314-3335. PubMed ID: 34766746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria.
    Cox G; Koteva K; Wright GD
    J Antimicrob Chemother; 2014 Jul; 69(7):1844-55. PubMed ID: 24627312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.
    Meng F; Liu Y; Nie T; Tang C; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
    Appl Environ Microbiol; 2022 May; 88(10):e0037122. PubMed ID: 35499329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane.
    Wang G; Brunel JM; Rodriguez-Villalobos H; Bolla JM; Van Bambeke F
    Eur J Med Chem; 2022 Aug; 238():114496. PubMed ID: 35691172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
    Hashem AA; Abd El Fadeal NM; Shehata AS
    J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
    Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
    Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of outer membrane disruptor SLAP-S25 with hydrophobic antibiotics against Gram-negative pathogens.
    Yang Z; Song M; Li X; Zhang Q; Shen J; Zhu K
    J Antimicrob Chemother; 2022 Dec; 78(1):263-271. PubMed ID: 36385317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phentolamine Significantly Enhances Macrolide Antibiotic Antibacterial Activity against MDR Gram-Negative Bacteria.
    Cui ZH; He HL; Zheng ZJ; Yuan ZQ; Chen Y; Huang XY; Ren H; Zhou YF; Zhao DH; Fang LX; Yu Y; Liu YH; Liao XP; Sun J
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial properties of an oligo-acyl-lysyl hexamer targeting Gram-negative species.
    Zaknoon F; Goldberg K; Sarig H; Epand RF; Epand RM; Mor A
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4827-32. PubMed ID: 22751534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.